Literature DB >> 8989682

Tracer selection with different stress modalities based on tracer kinetics.

G V Heller1.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8989682     DOI： 10.1016/s1071-3581(96)90203-2

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  19 in total

Review 1.  Pharmacologic stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease.

Authors:  A S Iskandrian; M S Verani; J Heo
Journal:  J Nucl Cardiol       Date:  1994 Jan-Feb       Impact factor: 5.952

2.  Coronary dilation with standard dose dipyridamole and dipyridamole combined with handgrip.

Authors:  J D Rossen; I Simonetti; M L Marcus; M D Winniford
Journal:  Circulation       Date:  1989-03       Impact factor: 29.690

3.  Linear relationship between the distribution of thallium-201 and blood flow in ischemic and nonischemic myocardium during exercise.

Authors:  A P Nielsen; K G Morris; R Murdock; F P Bruno; F R Cobb
Journal:  Circulation       Date:  1980-04       Impact factor: 29.690

4.  Technetium 99m-labeled tetrofosmin myocardial tomography in patients with coronary artery disease: comparison between adenosine and dynamic exercise stress testing.

Authors:  A Cuocolo; E Nicolai; A Soricelli; L Pace; A Nappi; P Sullo; S Cardei; L Argenziano; P J Ell; M Salvatore
Journal:  J Nucl Cardiol       Date:  1996 May-Jun       Impact factor: 5.952

5.  Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions.

Authors:  G V Heller; S D Herman; M I Travin; J I Baron; C Santos-Ocampo; J R McClellan
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

6.  Influence of exercise intensity on the presence, distribution, and size of thallium-201 defects.

Authors:  G V Heller; I Ahmed; P L Tilkemeier; M M Barbour; C E Garber
Journal:  Am Heart J       Date:  1992-04       Impact factor: 4.749

7.  Hemodynamic and metabolic correlates of dipyridamole-induced myocardial thallium-201 perfusion abnormalities in multivessel coronary artery disease.

Authors:  D P McLaughlin; G A Beller; J Linden; C R Ayers; M L Ripley; H Taylor; D D Watson; M D Feldman
Journal:  Am J Cardiol       Date:  1994-06-15       Impact factor: 2.778

8.  Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise.

Authors:  H G Stratmann; B R Tamesis; L T Younis; M D Wittry; D D Miller
Journal:  Am J Cardiol       Date:  1994-04-01       Impact factor: 2.778

9.  Myocardial kinetics of Tc-MIBI in canine myocardium after dipyridamole.

Authors:  D K Glover; R D Okada
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

10.  Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia.

Authors:  A J Sinusas; Q Shi; M T Saltzberg; P Vitols; D Jain; F J Wackers; B L Zaret
Journal:  J Nucl Med       Date:  1994-04       Impact factor: 10.057
View more
  7 in total

1.  Diagnostic and prognostic applications for vasodilator stress myocardial perfusion imaging and the importance of radiopharmaceutical selection.

Authors:  R C Hendel
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

Review 2.  The clinical importance of electrocardiographic changes during pharmacologic stress testing with radionuclide myocardial perfusion imaging.

Authors:  Elizabeth M Cosmai; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2005 Jul-Aug       Impact factor: 5.952

3.  Is it possible for myocardial perfusion imaging to avoid missing any patients with high-risk coronary disease?

Authors:  Mark I Travin
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

4.  Factors affecting the myocardial activity acquired during exercise SPECT with a high-sensitivity cardiac CZT camera as compared with conventional Anger camera.

Authors:  Antoine Verger; Laetitia Imbert; Yalcine Yagdigul; Renaud Fay; Wassila Djaballah; François Rouzet; Nicolas Fourquet; Sylvain Poussier; Véronique Roch; Dominique Le Guludec; Gilles Karcher; Pierre-Yves Marie
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-08       Impact factor: 9.236

5.  Comparison of exercise, dipyridamole, adenosine, and dobutamine stress with the use of Tc-99m tetrofosmin tomographic imaging.

Authors:  M G Levine; A W Ahlberg; A Mann; M P White; C C McGill; C Mendes de Leon; J M Piriz; D Waters; G V Heller
Journal:  J Nucl Cardiol       Date:  1999 Jul-Aug       Impact factor: 5.952

6.  Larger perfusion defects with exercise compared with dipyridamole SPECT (exercise-dipyridamole mismatch) may reflect differences in epicardial and microvascular coronary dysfunction: when the stressor matters.

Authors:  Edoardo Verna; Luca Ceriani; Stefano Provasoli; Simone Scotti; Sergio Ghiringhelli
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

7.  CT angiography for evaluation of coronary artery disease in inner-city outpatients: an initial prospective comparison with stress myocardial perfusion imaging.

Authors:  Linda B Haramati; Jeffrey M Levsky; Vineet R Jain; Erik J Altman; Hugo Spindola-Franco; Shalini Bobra; Sanjay Doddamani; Mark I Travin
Journal:  Int J Cardiovasc Imaging       Date:  2008-11-02       Impact factor: 2.357
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.